126 related articles for article (PubMed ID: 23763304)
1. Overexpression of nucleolin and different expression sites both related to the prognosis of gastric cancer.
Qiu W; Zhou F; Zhang Q; Sun X; Shi X; Liang Y; Wang X; Yue L
APMIS; 2013 Oct; 121(10):919-25. PubMed ID: 23763304
[TBL] [Abstract][Full Text] [Related]
2. [Relations of transforming growth factor-beta1 expression to differentiation and prognosis of advanced gastric cancer].
Guo RF; Zang SZ; Zhang L; Li WM; Hu FL; Lü YY
Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(46):3249-54. PubMed ID: 17313802
[TBL] [Abstract][Full Text] [Related]
3. Expression of the antiapoptosis gene Survivin predicts poor prognosis of stage III gastric adenocarcinoma.
Song KY; Jung CK; Park WS; Park CH
Jpn J Clin Oncol; 2009 May; 39(5):290-6. PubMed ID: 19336448
[TBL] [Abstract][Full Text] [Related]
4. Cytoplasmic CD24 expression is a novel prognostic factor in diffuse-type gastric adenocarcinoma.
Chou YY; Jeng YM; Lee TT; Hu FC; Kao HL; Lin WC; Lai PL; Hu RH; Yuan RH
Ann Surg Oncol; 2007 Oct; 14(10):2748-58. PubMed ID: 17680316
[TBL] [Abstract][Full Text] [Related]
5. High levels of nucleolar expression of nucleolin are associated with better prognosis in patients with stage II pancreatic ductal adenocarcinoma.
Peng L; Liang J; Wang H; Song X; Rashid A; Gomez HF; Corley LJ; Abbruzzese JL; Fleming JB; Evans DB; Wang H
Clin Cancer Res; 2010 Jul; 16(14):3734-42. PubMed ID: 20628027
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of Cullin1 is associated with poor prognosis of patients with gastric cancer.
Bai J; Zhou Y; Chen G; Zeng J; Ding J; Tan Y; Zhou J; Li G
Hum Pathol; 2011 Mar; 42(3):375-83. PubMed ID: 21190721
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of matrix metalloproteinase 11 in human gastric carcinoma and its clinicopathologic significance.
Zhao ZS; Chu YQ; Ye ZY; Wang YY; Tao HQ
Hum Pathol; 2010 May; 41(5):686-96. PubMed ID: 20060156
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of tumor suppressor QKI in gastric cancer and its implication in cancer prognosis.
Bian Y; Wang L; Lu H; Yang G; Zhang Z; Fu H; Lu X; Wei M; Sun J; Zhao Q; Dong G; Lu Z
Biochem Biophys Res Commun; 2012 May; 422(1):187-93. PubMed ID: 22569043
[TBL] [Abstract][Full Text] [Related]
9. Vimentin expression is associated with decreased survival in gastric cancer.
Otsuki S; Inokuchi M; Enjoji M; Ishikawa T; Takagi Y; Kato K; Yamada H; Kojima K; Sugihara K
Oncol Rep; 2011 May; 25(5):1235-42. PubMed ID: 21327330
[TBL] [Abstract][Full Text] [Related]
10. Clinical and prognosis relevance of COX-2 expression in Tunisian patients with primary gastric adenocarcinoma.
Ben Ayed-Guerfali D; Charfi S; Khabir A; Sellami-Boudawara T; Gargouri A; Mokdad-Gargouri R
Cancer Biomark; 2016 Jun; 17(1):67-73. PubMed ID: 27314294
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of nuclear or cytoplasmic nucleolin expression in human non-small cell lung cancer and its relationship with DNA-PKcs.
Xu JY; Lu S; Xu XY; Hu SL; Li B; Li WX; Chang JY
Tumour Biol; 2016 Aug; 37(8):10349-56. PubMed ID: 26846099
[TBL] [Abstract][Full Text] [Related]
12. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of nuclear protein kinase CK2 Beta subunit and prognosis in human gastric carcinoma.
Lin KY; Fang CL; Chen Y; Li CF; Chen SH; Kuo CY; Tai C; Uen YH
Ann Surg Oncol; 2010 Jun; 17(6):1695-702. PubMed ID: 20087779
[TBL] [Abstract][Full Text] [Related]
14. TGFbeta1, TGFbeta2, and TGFbeta3 protein expression in gastric carcinomas: correlation with prognostics factors and patient survival.
Vagenas K; Spyropoulos C; Gavala V; Tsamandas AC
J Surg Res; 2007 May; 139(2):182-8. PubMed ID: 17270215
[TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase-2 is an independent prognostic factor in gastric cancer and its expression is regulated by the messenger RNA stability factor HuR.
Mrena J; Wiksten JP; Thiel A; Kokkola A; Pohjola L; Lundin J; Nordling S; Ristimäki A; Haglund C
Clin Cancer Res; 2005 Oct; 11(20):7362-8. PubMed ID: 16243808
[TBL] [Abstract][Full Text] [Related]
16. Altered expression of estrogen receptor alpha and beta in advanced gastric adenocarcinoma: correlation with prothymosin alpha and clinicopathological parameters.
Wang M; Pan JY; Song GR; Chen HB; An LJ; Qu SX
Eur J Surg Oncol; 2007 Mar; 33(2):195-201. PubMed ID: 17046193
[TBL] [Abstract][Full Text] [Related]
17. Perineural invasion after preoperative chemotherapy predicts poor survival in patients with locally advanced gastric cancer: gene expression analysis with pathologic validation.
Jhawer M; Coit D; Brennan M; Qin LX; Gonen M; Klimstra D; Tang L; Kelsen DP; Shah MA
Am J Clin Oncol; 2009 Aug; 32(4):356-62. PubMed ID: 19381079
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of nucleophosmin/B23 and human epidermal growth factor receptor 2/neu expressions in gastric cancers.
Zhou F; Qiu W; Sun L; Xiang J; Sun X; Sui A; Ding A; Yue L
APMIS; 2013 Jul; 121(7):582-91. PubMed ID: 23489260
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of IFITM1 has clinicopathologic effects on gastric cancer and is regulated by an epigenetic mechanism.
Lee J; Goh SH; Song N; Hwang JA; Nam S; Choi IJ; Shin A; Kim IH; Ju MH; Jeong JS; Lee YS
Am J Pathol; 2012 Jul; 181(1):43-52. PubMed ID: 22609115
[TBL] [Abstract][Full Text] [Related]
20. PAI-1 expression levels in gastric cancers are closely correlated to those in corresponding normal tissues.
Sakakibara T; Hibi K; Koike M; Fujiwara M; Kodera Y; Ito K; Nakao A
Hepatogastroenterology; 2008; 55(85):1480-3. PubMed ID: 18795717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
